Bcl-2-associated proteins
AssigneeLa Jolla Cancer Research Foundation
InventorsJohn C. Reed, Shinichi Takayama, Takaaki Sato
Life of this patent
Estimating the term…
Loading patent…
AssigneeLa Jolla Cancer Research Foundation
InventorsJohn C. Reed, Shinichi Takayama, Takaaki Sato
Estimating the term…
The present invention provides nucleotide sequences encoding proteins and fragments thereof that bind to Bcl-2-related proteins. The invention also provides a Bcl-2-associated protein (BAP) such as Bcl-2-associated protein-1 (BAP-1), which binds to Bcl-2. The invention also provides antibodies that specifically bind to a BAP. The invention further provides methods for detecting agents such as drugs that alter the binding of a BAP such as BAP-1 or Raf-related protein with a Bcl-2-related protein and methods for detecting agents that induce dissociation of a bound complex formed by the association of a BAP and a Bcl-2-related protein. The invention further provides methods for modulating the activity of a Bcl-2-related protein in a cell by introducing into the cell a nucleic acid encoding a BAP or by introducing into the cell an antisense nucleotide sequence, which is complementary to a region of a gene encoding a BAP.
A nucleic acid molecule having a nucleotide sequence selected from the group consisting of SEQ ID NO:
A nucleotide sequence complementary to a nucleotide sequence selected from the group consisting of SEQ ID NO:
Dependencies are inferred from the claim text.